HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bharat Rekhi Selected Research

Synaptophysin

1/2022A unique case of adamantinoma-like Ewing sarcoma in the calcaneus, exhibiting prominent squamous differentiation and displaying EWSR1 gene rearrangement.
12/2020Clinicopathologic, immunohistochemical, molecular cytogenetic profile with treatment and outcomes of 34 cases of Ewing sarcoma with epithelial differentiation, including 6 cases with "Adamantinoma-like" features, diagnosed at a single institution, India.
10/2015Clinicopathological spectrum of a series of Merkel cell carcinomas diagnosed at a tertiary cancer referral center in India, with current concepts.
7/2014Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
11/2013Metastatic paraganglioma presenting as a primary shoulder mass.
2/2013Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
12/2011Epithelioid malignant peripheral nerve sheath tumor of the uterine corpus.
8/2011Melanotic neuroectodermal tumor of infancy in thigh of an infant--a rare case report with diagnostic implications.
3/2010Pulmonary non-Hodgkin's lymphoma (NHL) of diffuse large B-cell type with simultaneous humeral involvement in a young lady: an uncommon presentation with cytologic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bharat Rekhi Research Topics

Disease

69Neoplasms (Cancer)
12/2022 - 02/2007
9Sarcoma (Soft Tissue Sarcoma)
07/2021 - 01/2010
8Osteosarcoma (Osteogenic Sarcoma)
11/2021 - 01/2013
6Neoplasm Metastasis (Metastasis)
02/2022 - 10/2007
5Rhabdomyosarcoma
06/2022 - 05/2014
5Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 09/2012
5Chordoma
11/2021 - 08/2010
4Ewing Sarcoma (Sarcoma, Ewing)
01/2022 - 07/2017
4Ovarian Epithelial Carcinoma
02/2020 - 10/2016
3Adenocarcinoma
09/2012 - 09/2008
2Pain (Aches)
11/2021 - 01/2013
2Melanoma (Melanoma, Malignant)
01/2021 - 04/2018
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2019
2Endometrial Neoplasms (Endometrial Cancer)
08/2020 - 10/2015
2Synovial Sarcoma (Synovioma)
01/2020 - 12/2013
2Endometrial Stromal Sarcoma
10/2019 - 10/2014
2Giant Cell Tumors (Giant Cell Tumor)
01/2017 - 10/2015
2Leiomyoma (Uterine Fibroids)
07/2015 - 02/2015
1Virus Diseases (Viral Diseases)
05/2022
1Primitive Neuroectodermal Tumors (PNET)
01/2022
1Chondrosarcoma
11/2021
1Pseudarthrosis (Pseudoarthrosis)
05/2021
1Tuberculosis (Tuberculoses)
04/2021
1Anemia
01/2021
1Liposarcoma
10/2020
1COVID-19
04/2020
1Chondroblastoma
02/2020
1Merkel Cell Carcinoma
12/2019
1Uterine Hemorrhage (Uterine Bleeding)
08/2019
1Cysts
08/2019

Drug/Important Bio-Agent (IBA)

18Keratins (Keratin)IBA
01/2022 - 03/2007
14DesminIBA
06/2022 - 03/2011
13Mucin-1 (CA 15-3 Antigen)IBA
12/2021 - 03/2010
13VimentinIBA
12/2021 - 02/2007
9SynaptophysinIBA
01/2022 - 03/2010
8S100 Proteins (S 100 Protein)IBA
12/2021 - 08/2010
7Brachyury protein (Brachyury)IBA
12/2021 - 08/2010
6MyogeninIBA
06/2022 - 12/2011
5ParaffinIBA
12/2021 - 12/2011
5Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 04/2016
5ChromograninsIBA
10/2015 - 03/2010
4IfosfamideFDA LinkGeneric
01/2022 - 11/2017
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2017
4Pharmaceutical PreparationsIBA
01/2020 - 04/2016
4MART-1 AntigenIBA
08/2017 - 12/2011
4Estrogen ReceptorsIBA
11/2015 - 07/2012
4Progesterone Receptors (Progesterone Receptor)IBA
11/2015 - 07/2012
3Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 01/2020
3PlatinumIBA
01/2022 - 01/2020
3ChromatinIBA
03/2021 - 11/2013
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 11/2017
3Proteins (Proteins, Gene)FDA Link
08/2020 - 10/2015
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020 - 11/2017
3Phosphopyruvate Hydratase (Enolase)IBA
02/2013 - 03/2010
2DenosumabFDA Link
06/2022 - 01/2017
2Calmodulin-Binding Proteins (Caldesmon)IBA
06/2022 - 03/2011
2Biomarkers (Surrogate Marker)IBA
05/2022 - 02/2020
2Vincristine (Oncovin)FDA LinkGeneric
01/2022 - 01/2021
2Etoposide (VP 16)FDA LinkGeneric
01/2022 - 01/2021
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2021
2AntigensIBA
04/2021 - 04/2018
2Calbindin 2IBA
07/2020 - 07/2010
2Formaldehyde (Formol)FDA Link
01/2020 - 12/2013
2Cyclin D1IBA
10/2019 - 10/2014
2Fluorine-18IBA
06/2019 - 04/2015
2Transcription Factors (Transcription Factor)IBA
12/2016 - 08/2010
2Keratin-7 (Cytokeratin 7)IBA
10/2015 - 09/2008
2CalponinsIBA
07/2014 - 12/2011
2Melanins (Melanin)IBA
07/2012 - 08/2011
1KIR ReceptorsIBA
05/2022
1GemcitabineFDA Link
02/2022
1AnthracyclinesIBA
02/2022
1Insulin-Like PeptidesIBA
01/2022
1GlypicansIBA
12/2021
1Interleukin-6 (Interleukin 6)IBA
08/2021
1pazopanibFDA Link
07/2021
1Genetic Markers (Genetic Marker)IBA
07/2021
1Tumor Biomarkers (Tumor Markers)IBA
04/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1trametinibIBA
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
01/2021
1Biological ProductsIBA
04/2020
1Insulin (Novolin)FDA Link
01/2020
1AntibodiesIBA
12/2019
1Tumor Viral Antigens (Large T Antigen)IBA
12/2019
1CAM 5.2 antigenIBA
08/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2019

Therapy/Procedure

15Drug Therapy (Chemotherapy)
12/2022 - 01/2013
8Radiotherapy
01/2022 - 08/2011
7Therapeutics
01/2022 - 02/2013
6Hysterectomy
08/2019 - 12/2011
4Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 11/2017
4Neoadjuvant Therapy
01/2021 - 01/2013
2Operative Surgical Procedures
07/2021 - 01/2017
2Salpingo-oophorectomy
08/2019 - 10/2015
1Adjuvant Chemotherapy
12/2022
1Palliative Care (Palliative Therapy)
02/2022
1Nephrectomy
12/2021
1Hemipelvectomy
05/2021
1Limb Salvage
01/2019